Introduction to the Editors
Claude Hughes, MD, Ph.D. holds current Board Certification in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility from the American Board of Obstetrics and Gynecology. Since joining Quintiles /IQVIA in 2001. Dr. Hughes has served as a Medical Advisor on clinical trials or in due diligence assessment teams that evaluated pharmaceuticals, devices or tests for multiple medical indications. Before joining Quintiles, Dr. Hughes held academic, research, administrative and clinical practice positions for 15 years in divisions of reproductive endocrinology & infertility in departments of obstetrics & gynecology and clinical and research centers within university-affiliated medical centers. His leadership roles included Director of the Reproductive Hormone [hormone assay service] Lab at Duke University for ten years; Section Leader, Department of Comparative Medicine at Wake Forest University, Director of the Center for Women’s Health at UCLA-Cedars Sinai Medical Center, and Vice President & Chief Medical Officer at RTI International.
Fengyu Zhang, MMed, Ph.D. MS, is Managing Director of Global Clinical and Translational Research Institute, Bethesda, MD and held invited distinguished adjunct professorships at the Second Xiangya Hospital of the Central South University, Peking University Beijing Huilongguan Hospital, Zhejiang University in China. He served as director of statistical genetics and senior genetic epidemiologist at National Institute of Mental Health (NIMH)’s Genes, Cognition, and Psychosis Program, and Investigator in Section of Genetics, Bioinformatics, and Epigenetics, Division of Clinical Sciences at the Lieber Institute for Brain Development, Johns Hopkins Medical Campus in Baltimore, MD, Statistical Geneticist (lead in statistical genetics) at Research Triangle Institute, Research Triangle Park, North Carolina. His research interests include genetic, social and environmental etiology of complex human diseases and health conditions, pharmacogenomics, precision medicine and population health, research methodology including those in clinical and translational research.
Dr. Zhang received a Master’s degree in preventive medicine from the Chinese Academy of Preventive Medicine (currently known as the Chinese Centers for Disease Control and Prevention) in Beijing, MS in statistics from the University of North Carolina at Chapel Hill, and Ph.D. from Peking University, with joint Ph.D. training and dissertation research at the University of North Carolina at Chapel Hill. He conducted his postdoctoral research and training in maternal and child health/biostatistics at the UNC Chapel Hill and in population aging, health and policy at Duke University, Durham, NC. Dr. Zhang is a member of the American Association for the Advancement of Science, International Society for Developmental Origins of Health and Disease, the Society for Neuroscience, International Society of Psychiatric Genetics, and Foreign Associate of the Royal Society of Medicine, UK.
Donald Mattison, MD, is Chief Medical Officer and Senior Vice President of Risk Sciences International. Dr. Mattison also serves as Associate Director of the McLaughlin Centre for Population Health Risk Assessment at the University of Ottawa, Canada. He has held academic, clinical and research appointments, including Senior Advisor to the Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Medical Director of the March of Dimes; Dean of the Graduate School of Public Health at the University of Pittsburgh, Professor of Obstetrics and Gynecology and Inter-disciplinary Toxicology at the University of Arkansas for Medical Sciences, and Director of Human Risk Assessment at the FDA National Center for Toxicological Research.
Dr. Mattison was elected a Fellow of the American Association for the Advancement of Science, a Fellow of the New York Academy of Medicine, and a member of the US National Academy of Medicine, Distinguished Alumni of Augsburg College and a Fellow of the Royal Society of Medicine.
Senior Associate Editor
David St Clair, MD Ph.D., is Professor in Psychiatry at the University of Aberdeen in Scotland, UK and Honorary Consultant Psychiatrist with NHS Grampian, was elected as a Fellow of the Royal Society of Edinburgh. Dr. St Clair has made a significant contribution to the genetics of schizophrenia and is part of both the International Schizophrenia and SGENE consortia who are performing genome wide studies of DNA from large numbers of schizophrenia cases and controls. Other ongoing studies in Aberdeen include schizophrenia bio-marker development and translational studies in Disc-1 transgenic mice.
Dr. St Clair holds an advisory professorship at Shanghai Jiaotong University and an adjunct professorship at Columbia University. He has identified pre-natal nutritional deficiency as a major environmental risk factor for schizophrenia and in collaboration with colleagues at Jiaotong and Shanghai large scale field studies have begun to identify the mechanisms responsible.
Hong-Wen Deng, Ph.D., is Endowed Chair and Professor of Biostatistics at School of Public Health and Tropic Medicine at the Tulane University. Deng’s work is published in more than 500 peer-reviewed publications including journals such as Nature, New Engl J Medicine, American Journal of Human Genetics, Endocrine Review, PLoS Genetics, Human Molecular Genetics, Molecular Psychiatry, Bioinformatics, and Molecular Cell Proteomics.
Xu-Feng Huang, MD, Ph.D., DSc, is Distinguished Professor, School of Medicine; Theme Leader of Mental Health (Clinic) of Illawarra Health and Medical Research Institute; Director, Centre for Translational Neuroscience; Faculty of Science, Medicine, and Health, University of Wollongong (UOW), Australia.
Qianjin Lu, MD, Ph.D., is currently a Professor and Director of Institute of Dermatology at the Central South University, Director of Hunan Key Laboratory of Medical Epigenomics, President of Chinese Society of Dermatology. His research focus on the epigenetics of autoimmune and inflammatory-related skin diseases, including lupus, psoriasis and atopic dermatitis. He has authored over 200 publications, book chapters and review articles. Dr. Lu is on editorial board of several journals and has been appointed as an associate editor of Clinical Immunology. He has received numerous awards, including the Award of International League of Dermatological Societies, the Second Prize of National Scientific and Technological Progress, the First Prize of Natural Scientific Research of Hunan Province, the First Prize of Scientific and Technological Progress of Hunan Province and Outstanding Medical Scientist of China. Dr. Lu practices clinical care and teaches in the dermatology, and has extensive clinical experiences in dermatology and especially in lupus and psoriasis.
Susan Sumner, Ph.D., is Professor of Nutrition at the University of North Carolina at Chapel Hill and Director of the NIH Eastern Regional Comprehensive Metabolomics Resource Core. Dr. Sumner’s expertise is in metabolism and metabolomics, and broad applications in studies of diet, smoking, cancer, diabetes, obesity, cognitive development, liver disease, natural products, maternal and child health, and the environmental influence of disease complements the nutrigenomics research.
Xiaoli Tian, PhD, is Professor and Dean of the College of Life Sciences and Director of the Institute of Human Aging, Nanchang University. Dr. Tian was a Chief Scientist and Director of the 973 program projects supported by the Ministry of Science and Technology on “Vascular aging and related diseases of the biological basis”. His research team is mainly focused on using population genetics, model animals and other approaches to study the genetic mechanism of cardiovascular aging and aging-related cardiovascular and cerebrovascular diseases.
Riqiang Yan, Ph.D., is Professor and Chair of Neuroscience at The University of Connecticut School of Medicine. Prior to that, Dr. Yan served as Cleveland Clinic’s Morris R and Ruth Graham Endowed Chair Professor and Vice Chair of Neuroscience and Professor of molecular medicine at Case Western Reserve University, Cleveland, OH. He is a recipient of MetLife Award for Medical Research (the prestigious award for Alzheimer’s Research), Award for outstanding science at Cleveland Clinic Foundation and Ralph Wilson Award.
Hui Zhang, Ph.D., is Professor of Biostatistics in the Department of Preventive Medicine at the Northwestern University in Chicago, IL. Prior to that he worked at St Jude Children’s Research Hospital, Memphis, TN. His research interests focus on longitudinal data analysis, survival data analysis, computational neuroscience and count data in next-generation sequence.
Youwen Zhou, MD Ph.D., is Professor and physician-scientist in dermatology at the Department of Dermatology and Skin Science of the University of British Columbia. Dr. Zhou is the past president of the Canadian Society of Investigative Dermatology and served as an ad board member for CIHR Institute of Musculoskeletal Health and Arthritis (IMHA). Dr. Zhou has received multiple national and international awards, including Barney Usher Award for Outstanding Achievements from the Canadian Dermatology Association.